Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 6, 2001, Pages 515-524

  Briganti, V ^a   Matteini, M ^a   Ferri, P ^a   Vaggelli, L ^a   Castagnoli, A ^a   Pieroni, C ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECHOGRAPHY; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; INSULINOMA; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; MEDICAL DECISION MAKING; NEUROENDOCRINE TUMOR; OCTSPET; PANCREAS TUMOR; PRIORITY JOURNAL; RECEPTOR AFFINITY; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY;

EID: 0035660790     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/10849780152752119     Document Type: Article

References (31)

1. In vivo use of radioiodinated Somatostatin analogue: Dynamic, metabolism and binding to Somatostatin receptor-positive tumors in man
2. In vivo application of [In-111-DTPA-D-Phe]-octretide for detection of somato-statin receptor-positive tumors in rats
3. Somatostatin receptor scintigraphy with Indium-111-DTPA-D-Phe-l-octretide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octretide
4. Somatostatin receptor scintigraphy with [111-Indium-DTPA-D-Phe-1]- and [123-Iodine-Tyr]-octretide: The Rotterdam experience with more of 1000 patients
5. Radionuclide imaging of neuroendocrine tumors: Biological basis and diagnosis results
6. Peptide therapy. Recent advances in the use of Somatostatin and others peptide receptor agonist and antagonist
7. Clinical impact of Somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroentero-pancreatic tumors
8. Comparison of Somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastroenteropancreatic tumors
9. Neuroendocrine gastrointestinal tumors
10. Cytology of tumors in the gastroenteropancreatic and diffuse neuroendocrine system
11. Endocrine tumors of the gastrointestinal tract
12. Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumors
13. Imaging of somatostatin receptors by Indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors
14. Characterization of an ectopic secreting carcinoid with 111-In-DTPA-D-Phe-octretide
15. Quantification of somatostatin receptor scintigraphy in neuroendocrine tumors: A new prognostic approach
16. Comparison of 111-In-DOTA-Tyr-3-octretide and 111-In-DTPA-pentetreotide in the same patients: Biodistribution, kinetics, organ and tumor uptake
17. Receptor scintigraphy with 111-In-pentreotide for endocrine gastroentero-pancreatic tumors
18. SPECT improves accuracy of somostatin receptor scintigraphy in abdominal carcinoid tumors
19. Somatostatin receptor scintigraphy of carcinoid tumors using [111-In-DTPA-D-Phe-1]-octreotide
20. Localization of metastatic gastrointestinal-pancreatic tumors by somatostatin receptor scintigraphy with [111-In-DTPA-D-Phe-1]-octreotide
21. Use of isotopic Somatostatin receptor probe to image gut endocrine tumors
22. Somatostatin receptor imaging with Indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy, and impact on patient management
23. Specificity of somatostatin receptor scintigraphy: A prospective study and effect of false positive localizations on management in patients with gastrinomas
24. The role of Somatostatin and its analogs in the diagnosis and treatment of tumors
25. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinoma
26. Imaging neuroendocrine tumors with radiolabeled Somatostatin analogues and x-ray computed tomography: A comparative study
27. Molecular biology of somatostatin receptors
28. Localization and surgical treatment of occult insulinoma
29. An odyssey in the land of small tumors
30. Oncological applications of somatostatin analogues
31. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms